Stenocare AS (FRA:S7C) Ending Cash Position: €0.09 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:S7C Stenocare AS FRA:S7C
39 GF Score
Price €0.13
GF Value €0.30
! 4 Warning Signs
View Full Analysis

What is Stenocare AS Ending Cash Position?

Stenocare AS FRA:S7C -2.32% 39 Ending Cash Position is €0.09 Mil as of Mar. 2026. GuruFocus rates FRA:S7C with a GF Score™ of 39/100 and a GF Value™ of €0.30. The stock has 4 warning signs investors should review.

Stenocare AS's Ending Cash Position for the quarter that ended in Mar. 2026 was €0.09 Mil.

Stenocare AS's quarterly Ending Cash Position declined from Sep. 2025 (€0.61 Mil) to Dec. 2025 (€0.11 Mil) and declined from Dec. 2025 (€0.11 Mil) to Mar. 2026 (€0.09 Mil).

Stenocare AS's annual Ending Cash Position declined from Dec. 2023 (€1.27 Mil) to Dec. 2024 (€0.19 Mil) and declined from Dec. 2024 (€0.19 Mil) to Dec. 2025 (€0.11 Mil).

Stenocare AS Ending Cash Position Related Terms

Stenocare AS Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Stenocare AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stenocare AS Ending Cash Position Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 1.58 0.60 1.27 0.19 0.11

Stenocare AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.65 0.61 0.11 0.09
FRA:S7C
39GF Score
Stenocare AS FRA:S7C
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stenocare AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Stenocare AS's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.184+-0.079
=0.11

Stenocare AS's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.137+-0.05
=0.09

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €0.09 Mil mean?
Stenocare AS (FRA:S7C) has a Ending Cash Position of €0.09 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Stenocare AS and its competitors.
Is Stenocare AS's Ending Cash Position too high?
Stenocare AS's current Ending Cash Position is €0.09 Mil. Overall, Stenocare AS has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Stenocare AS's Ending Cash Position compare to ZTS and UTHR?
Stenocare AS's Ending Cash Position of €0.09 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Stenocare AS and its competitors. Stenocare AS's current Ending Cash Position is €0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stenocare AS stock overvalued right now?
Stenocare AS (FRA:S7C) has a current Ending Cash Position of €0.09 Mil. The stock's GF Value™ is €0.30, compared to a current price of €0.13 — trading 57.8% below its estimated fair value. The current Ending Cash Position is €0.09 Mil. Stenocare AS's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Stenocare AS (FRA:S7C), the current Ending Cash Position is €0.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stenocare AS (FRA:S7C) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of €0.13 is trading 57.8% below its estimated GF Value™ of €0.30.

Key valuation signals for FRA:S7C:

  • Ending Cash Position: €0.09 Mil
  • GF Value™: €0.30 vs. price of €0.13 (57.8% below fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the FRA:S7C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stenocare AS Business Description

Other Exchanges STENO:Denmark
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
39GF Score

Get the complete analysis for FRA:S7C

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price
€0.30
GF Value